Sound waves vs. breast cancer: new device tested

NCT ID NCT05291507

Recruiting now Disease control Sponsor: University of Utah Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early study tests a device called Muse MRgFUS that uses focused ultrasound waves to heat and destroy a portion of a breast tumor without any cuts. Thirty-four women with breast cancer will have part of their tumor ablated before their standard surgery. The goal is to see if the procedure is safe, tolerable, and feasible.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Muse MRgFUS System (a device that uses focused ultrasound to heat and destroy tissue non-invasively)
What this could lead to: If successful, this could lead to a non-invasive option to shrink breast tumors, potentially reducing the need for more extensive surgery.
What could go wrong: This is a very early feasibility study with only 34 participants, so results may not apply widely. The device only treats part of the tumor, and safety or effectiveness are not yet proven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm invasive breast carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER

Contacts and locations

Locations

Huntsman Cancer Institute at University of Utah
RECRUITING

Salt Lake City, Utah, 84112, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.